ADVICENNE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.68 EUR | -1.75% |
|
-0.59% | -36.84% |
| 04-08 | Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-25 | Advicenne: ODD designation in cystinuria | CF |
Chart calendar Advicenne
d.QMZ8NoJPF73vf-PlLI6TTtBEbTDdABICBNTO7oAf8M4.bYAxB-t6U8jCC9q8a9-lfIkIKUe8ZENzQZysitR33Z4OhC590SZjyqEWkA~9d9d9779f71225af264caf61726ede02
Upcoming events on Advicenne
Past events on Advicenne
| 28/03/2024 06:30 | Q4 2023 Earnings Release |
| 23/01/2024 17:00 | Q4 2023 Sales and Revenue Release |
| 08/10/2023 | Investor Access Conference |
| 27/09/2023 | EUROPEAN SOCIETY FOR PAEDIATRIC NEPHROLOGY MEETING |
| 11/09/2023 17:00 | Q2 2023 Earnings Release |
| 14/06/2023 | European Renal Association Congress |
| 08/06/2023 09:00 | Annual General Meeting |
| 04/06/2023 | Bio International Convention |
| 04/06/2023 | UK Kidney Week |
| 10/05/2023 | TP ICAP Midcap Conference |
| 03/04/2023 | Investor Access Conference |
| 31/03/2023 10:30 | Q4 2022 Earnings Call |
| 30/03/2023 19:45 | Q4 2022 Earnings Release |
| 08/01/2023 | JP Morgan Healthcare Conference |
| 14/11/2022 | Jefferies London Healthcare Conference |
| 20/09/2022 06:00 | Interim 2022 Earnings Release |
| 08/06/2022 | Annual General Meeting |
| 31/03/2022 17:28 | FY 2021 Earnings Release |
| 29/09/2021 06:00 | Interim 2021 Earnings Release |
| 14/06/2021 10:00 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 2,58 8,07 -67.96% | 3,56 2,92 22.13% | 3,30 3,11 6.28% | 2,34 3,43 -31.81% | 2,94 3,70 -20.49% | 4,20 |
|
EBITDA Million EUR | Released Forecast Spread | -13,7 -13,3 -2.86% | -13,9 -24,0 41.95% | -12,0 -7,96 -51.01% | -9,73 -9,73 0.06% | -6,25 -2,00 -212.3% | -5,90 |
|
EBIT Million EUR | Released Forecast Spread | -14,2 -13,6 -4.66% | -14,1 -24,5 42.31% | -12,4 -8,38 -48.46% | -10,1 -10,1 0.73% | -6,46 -2,40 -169.04% | -6,30 |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
Net income Million EUR | Released Forecast Spread | -13,7 -13,5 -1.68% | -14,8 -24,4 39.24% | -12,4 -8,31 -49.59% | -11,5 -10,8 -6.08% | -7,03 -3,15 -123.21% | -7,90 |
|
EPS EUR | Released Forecast Spread | -1,74 -1,67 -4.01% | -1,76 -2,91 39.44% | -1,34 -0,23 -493.55% | -1,16 -0,62 -87.96% | -0,67 -0,74 9.4% | -0,64 |
| Announcement Date | 13/03/20 | 28/04/21 | 31/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 |
|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 1,10 |
|
Net income Million EUR | Released Forecast Spread | -7,70 |
|
EPS EUR | Released Forecast Spread | -0,92 |
| Announcement Date | 25/09/20 |
More events
Past sector events for Advicenne
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALDVI Stock
- Calendar Advicenne
